Meetings and Courses

Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication. This list is provided as a service to readers; inclusion does not imply endorsement by the Hepatobiliary & Pancreatic Diseases International.

Section editor

Shui-Ying Lei

Email: hbpdint@126.com

September, 2015

EASL/AASLD monothematic conference: autoimmune hepatitis

September 3-5, 2015; London, United Kingdom

This meeting is sponsored by The European Association of the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD). This two-day meeting will cover a variety of concepts of the pathogenesis of autoimmune hepatitis and various aspects of clinical knowledge, highlighting recent advances as well as focusing on research needs. The program is designed to foster interaction among presenters and attendees in a plenary session venue. For more information, please visit: http://www.aasld.org/eventsprofessional-development/easlaasld-monothematicconference-autoimmune-hepatitis#sthash.n0U8F5BD. dpuf.

27th European congress of pathology (Pathologybreaking barriers in medicine)

September 5-9, 2015; Sava Center, Belgrade, Seria

The theme for the 2015 ECP congress pathology-breaking barriers in medicine is therefore very timely: pathologists have many interactions with other disciplines and its developments have influences on medical decision in everyday practice. The congress will have the organbased session as programmed by working groups, the special session on teaching, quality assessment and public awareness, and of course the key-note lectures enlighten pathologists on developments outside pathology, but influencing pathologists very much. The official language of the congress is English. For more information, please visit: http://www.esp-congress.org/.

CRI-CIMT-EATI-AACR-the inaugural international cancer immunotherapy conference: translating science into survival

September 16-19, 2015; New York, USA

The inaugural meeting will take place at the Sheraton Times Square in New York City on September 16-19, 2015. Entitled "Translating Science into Survival," it will cover all areas of inquiry in cancer immunology and immunotherapy, including: immune regulation of T cell responsiveness, genomic methods for identifying tumor antigens, the tumor microenvironment, T cell therapies, checkpoint blockade, biomarkers, combinations, and the microbiome. This joint meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates. Continuing Medical Education Activity-AMA PRA Category 1 Credits is available. For more information, please visit: http://www.aacr.org/Meetings/Pages/ MeetingDetail.aspx?EventItemID=54#.VQfmJtJmS4I.

Chromatin and epigenetics in cancer

September 24-27, 2015; Loews Atlanta, Atlanta, GeorgiaConference co-chairpersons are Peter A. Jones, Van Andel Research Institute, Grand Rapids, Michigan; Sharon Y.R. Dent, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Charles W.M. Roberts, Dana-Farber Cancer Institute, Boston, Massachusetts. The focus of this special conference is to bring together outstanding basic, translational, and clinical cancer researchers to discuss their latest findings in the fields of chromatin and epigenetic regulation, transcription initiation, enhancers, control of transcriptional elongation, and more. And how these findings are being investigated and applied as therapies for cancer treatment will also be discussed in this conference. Continuing Medical Education Activity AMA PRA Category 1 CreditsTM is available. For more information, please visit: http://www.aacr.org/Meetings/Pages/MeetingDetail. aspx?EventItemID=48#.VQfkuNJmS4I.

The European cancer congress 2015

September 25-29, 2015; Messe Wien Exhibition & Congress Centre, Vienna, Austria

The 18th ECCO-40th ESMO European cancer congress will combine the united efforts of all partner organisations to continue positioning multidisciplinarity as the way forward for improving the prevention, diagnosis, treatment and care of cancer patients-placing the patient at the heart of all our efforts and discussions. For more information, please contact: Congress Secretariat, c/o ECCO-the European CanCer Organisation, Avenue E. Mounier 83, B-1200 Brussels. Tel: +32-2-775-02-01; Fax: +32-2-775-02-00; Email: ecc2015@ecco-org.eu. Website: http://www.europeancancercongress.org/.

November

Advances in pediatric cancer research: from mechanisms and models to treatment and survivorship

November 9-12, 2015; Florida, USA

This special conference will address the unique issues and challenges in investigating the biologic basis of childhood cancers and translating recent findings into new treatment approaches. Presentations will examine the most recent research on novel strategies for modeling pediatric cancers, basic and applied genomics, and the most difficult to treat pediatric cancers. Strategies for translating basic science findings into treatments with a clinical impact will be featured, including the most up-to-date findings on targeted therapeutics, resistance, and immunotherapy. Advances in our understanding of the early and late effects of treatment will also be featured. This conference will bring together basic, clinical, and translational researchers in the field of pediatric cancer with expertise ranging from the most recent advances in the basic mechanisms of childhood cancers to the application of these findings in the clinical setting. For more information, please visit: http://www.aacr.org/ Meetings/Pages/MeetingDetail.aspx?EventItemID=41#. VZ3bZ_nvPGg.

New horizons in cancer research conference: bringing cancer discoveries to patients

November 12-15, 2015; Shanghai Marriott Parkview Hotel, Shanghai, China

Conference co-chairpersons are Lewis C. Cantley from Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, New York; and Carlos L. Arteaga from Vanderbilt-Ingram Cancer Center at Vanderbilt University, Nashville, Tennessee. The meeting will serve as a dynamic platform for the advancement of cancer science and medicine, and for the establishment of new collaborations on an international scale. The highly engaging and interactive four-day multidisciplinary program will cover the entire cancer research spectrum--from basic, to translational, to clinical--drawing on the latest findings presented at the 106th Annual Meeting of the AACR to be held in Philadelphia, April 18-22, 2015. The meeting will feature talks from an outstanding roster of international speakers and local experts. For more information, please visit: http://aacr. com.cn/.

The Liver Meeting 2015?

November 13-17, 2015; San Francisco, CA, USA

The 2015 meeting programming has been refined as part of a major initiative of AASLD in order to reflect the rapid scientific advances in the field of hepatology, and improve the overall attendee experience. This meeting is to exchange the latest liver diseases research, discuss treatment outcomes, and interact with colleagues at the annual must-attend even in the science and practice of hepatology. For more information, please visit: http:// www.aasld.org/events-professional-development/livermeeting-2015#sthash.n6bpBw6B.dpuf.

December

CSHA/AACR joint meeting: big data, computation and systems biology in cancer

December 1-5, 2015; Suzhou Dushu Lake Conference Center, Suzhou, China

The conference will include eight oral sessions and one poster session covering the latest findings across many topics in big data, computation, and systems biology in cancer research. Many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions. Major topics include: systems biology, computational biology, functional screening and drug discovery, tumor heterogeneity, models and networks, regulation and signaling, and cancer genomics and bioinformatics. For more information, please visit: http://www.csh-asia. org/2015meetings/AACR.html.

10.1016/S1499-3872(15)60407-6)